Evidence map›Paper›PMID 29254499›Full record

ArticleStem cell research & therapy2017

Low-dose strontium stimulates osteogenesis but high-dose doses cause apoptosis in human adipose-derived stem cells via regulation of the ERK1/2 signaling pathway.

Abudousaimi Aimaiti, Asihaerjiang Maimaitiyiming, Xu Boyong, Kaisaier Aji, Cao Li, Lei Cui

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. SrO-Containing Bioactive Glasses in the SiOACS biomaterials science & engineering · 2025
    Review
  4. Article
  5. Review
  6. 3D-Printed Cell-Instructive Scaffolds Based onACS biomaterials science & engineering · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Harnessing strontium in regenerative dentistry: progress and perspectives.Frontiers in bioengineering and biotechnology · 2025
    Review
  11. Article
  12. Role of Adipose-Derived Mesenchymal Stem Cells in Bone Regeneration.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Biosynthesized Silver Nanoparticles fromCurrent pharmaceutical biotechnology · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Abudousaimi AimaitiDepartment of Joint Surgery, First Affiliated Hospital of Xinjiang Medical University, 137 Li Yu Shan Road, Urumqi, Xinjiang, 830054, People's Republic of China.
Asihaerjiang MaimaitiyimingDepartment of Joint Surgery, First Affiliated Hospital of Xinjiang Medical University, 137 Li Yu Shan Road, Urumqi, Xinjiang, 830054, People's Republic of China.
Xu BoyongDepartment of Joint Surgery, First Affiliated Hospital of Xinjiang Medical University, 137 Li Yu Shan Road, Urumqi, Xinjiang, 830054, People's Republic of China.
Kaisaier AjiDepartment of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830054, China.
Cao LiDepartment of Joint Surgery, First Affiliated Hospital of Xinjiang Medical University, 137 Li Yu Shan Road, Urumqi, Xinjiang, 830054, People's Republic of China. caolixjbone@163.com.
Lei CuiDepartment of Plastic Surgery, Institute of Medical Science, Beijing Shijitan Hospital Affiliated to Capital Medical University, 10 Tieyi Road, Beijing, 100038, People's Republic of China. cuileite@aliyun.com.
First Affiliated Hospital of Xinjiang Medical University · CNCapital Medical University · CN

Funding

Major projects in the Xinjiang Uygur Autonomous Region 201430123-3National Natural Science Foundation of China 81471798National Natural Science Foundation of China (CN) 81303065National Natural Science Foundation of China-Xinjiang joint fund U1503221
6 · The paper itself

Abstract

backgroundStrontium is a widely used anti-osteoporotic agent due to its dual effects on inhibiting bone resorption and stimulating bone formation. Thus, we studied the dose response of strontium on osteo-inductive efficiency in human adipose-derived stem cells (hASCs).

methodQualitative alkaline phosphatase (ALP) staining, quantitative ALP activity, Alizarin Red staining, real-time polymerase chain reaction and Western blot were used to investigate the in vitro effects of a range of strontium concentrations on hASC osteogenesis and associated signaling pathways.

resultsIn vitro work revealed that strontium (25-500 μM) promoted osteogenic differentiation of hASCs according to ALP activity, extracellular calcium deposition, and expression of osteogenic genes such as runt-related transcription factor 2, ALP, collagen-1, and osteocalcin. However, osteogenic differentiation of hASCs was significantly inhibited with higher doses of strontium (1000-3000 μM). These latter doses of strontium promoted apoptosis, and phosphorylation of ERK1/2 signaling was increased and accompanied by the downregulation of Bcl-2 and increased phosphorylation of BAX. The inhibition of ERK1/2 decreased apoptosis in hASCs.

conclusionLower concentrations of strontium facilitate osteogenic differentiation of hASCs up to a point; higher doses cause apoptosis of hASCs, with activation of the ERK1/2 signaling pathway contributing to this process.

Indexed as

ApoptosisCell DifferentiationCell ProliferationHumansMAP Kinase Signaling SystemOsteogenesisSignal TransductionStem CellsStrontiumStrontiumERK1/2 signaling pathwayHuman adipose-derived mesenchymal stem cellsOsteogenesisStrontium

Identifiers

PMID29254499
PMCPMC5735894
OpenAlexW2779800100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.